Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $219.76 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $193.07 | 2 | $0 (2022) |
| Veloxis Pharmaceuticals, Inc. | $26.69 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $109.65 | 2 | Alexion Pharmaceuticals, Inc. ($82.96) |
| 2020 | $110.11 | 1 | Alexion Pharmaceuticals, Inc. ($110.11) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $82.96 | General |
| Category: Rare Disease | ||||||
| 03/23/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Immunosuppresant | ||||||
| 02/27/2020 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $110.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 341 | 694 | $247,519 | $66,775 |
| 2022 | 10 | 557 | 891 | $306,272 | $73,318 |
| 2021 | 4 | 232 | 312 | $107,896 | $30,071 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 216 | 351 | $141,330 | $36,685 | 26.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 277 | $81,434 | $25,111 | 30.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 32 | 42 | $12,107 | $2,703 | 22.3% |
| 90947 | Dialysis procedure requiring repeat evaluation | Facility | 2023 | 12 | 24 | $12,648 | $2,276 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 184 | 310 | $124,000 | $34,805 | 28.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 72 | 169 | $49,348 | $13,451 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 98 | 107 | $31,779 | $7,845 | 24.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 121 | $24,442 | $6,667 | 27.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 42 | 80 | $9,040 | $2,370 | 26.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 26 | 28 | $8,988 | $2,027 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $5,600 | $1,755 | 31.3% |
| 50200 | Needle biopsy of kidney | Facility | 2022 | 16 | 17 | $41,361 | $1,702 | 4.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 19 | 21 | $4,641 | $1,101 | 23.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $3,718 | $965.05 | 26.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 11 | 11 | $3,355 | $630.18 | 18.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 113 | 160 | $64,000 | $18,618 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 92 | 124 | $36,828 | $9,680 | 26.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 12 | 12 | $3,852 | $961.56 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 16 | $3,216 | $811.05 | 25.2% |
About Ambreen Azhar
Ambreen Azhar is a Nephrology healthcare provider based in Nyc, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1669979720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ambreen Azhar has received a total of $219.76 in payments from pharmaceutical and medical device companies, with $109.65 received in 2022. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($219.76).
As a Medicare-enrolled provider, Azhar has provided services to 1,130 Medicare beneficiaries, totaling 1,897 services with total Medicare billing of $170,164. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Nyc, NY
- Active Since 04/06/2018
- Last Updated 04/06/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669979720
Products in Payments
- ULTOMIRIS (Biological) $82.96
- Envarsus (Drug) $26.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.